Editor's Picks Back « 1 2
3 4 5 6 7 ... » Next- Risks Found for Youths in New Antipsychotics
The New York Times - Bayer CEO says not vulnerable to takeover: paper
Reuters - Lawmakers investigate Wyeth vitamin claims
Reuters - Health Care Issue, Not Quite Hot, Remains Strong
The New York Times - Detailed Study on Spread of H.I.V. in U.S.
The New York Times - Glaxo creates new cancer drug group in R&D revamp
Reuters - Mini antibodies: biotech's next big thing?
Reuters - FDA hires 1,300 new doctors and scientists
The Associated Press - UMass starts a top stem-cell database
The Boston Hearld - Higher Bid for ImClone Puts Bristol on Defensive
The New York Times - University of Iowa sues Amgen for patent infringement
Press-citizen - Insurers recoup obesity surgery cost in 2-4 years
Reuters - More Asthma Among Those Near 9/11 Site
The New York Times - DOE awards $4.4M in grants for biofuel research
CNNMoney - Xoma explores biotech partnership with Texas A&M
CNNMoney - Back and Forth on Stem-Cell Research Energizes Race
The New York Times - Glaxo signs up to $1.5 billion drug deal with Cellzome
Reuters - Controversial stem-cell co. sinking in debt
The Boston Herald - Critical shortage of internal medicine MDs foreseen
Reuters - Group seeks end to gridlock on health reform
Reuters - The Pitfalls of Linking Doctors' Pay to Performance
The New York Times - For Stem Cells, a Role on the Battlefield
The New York Times - 23andMe slashes price on personal genetics test
The Associated Press - Exercise trumps obesity gene in study
Reuters - Hallucinogen' Popularity May Thwart Medical Use
The New York Times - Blood-boosting drug helps increase memory: study
Reuters - FDA lists drugs under safety probes
Reuters - Embryonic stem cells still needed, panel says
Reuters - Facing Veto, Democrats Drop Plan for Vote on Child Bill
The New York Times - Judge to Unseal Documents on the Eli Lilly Drug Zyprexa
The New York Times - Scientists are breeding genetically modified pigs for organs
The Canadian Press - Venture-backed cos. want piece of research pie
The Boston Herald - Vaccinations of Toddlers Set a Record
Reuters - Embryonic stem cells still needed, panel says
Reuters - For the Brain, Remembering Is Like Reliving
The New York Times - Arthritis Drugs Linked to Risks From Infection
The New York Times - Cancer Researchers Should Widen Genetic Focus, Studies Suggest
Bloomberg - Down's signs 'seen in stem cells'
BBC - Pfizer invests in S.F. biotech firm's drug
The San Francisco Chronicle - U.S. study clears measles vaccine of autism link
Reuters - Biotech group not endorsing for prez, but seeks more in FDA budget
The Boston Herald - In Studies of Virtual Twins, Nature Wins Again
The New York Times - Czech city bids to be global biotech hub
Reuters - Biofuel researchers look for the good in stinkweed
The Associated Press - For Widely Used Drug, Question of Usefulness Is Still Lingering
The New York Times - VC Funding for Biotech Companies Withering
GEN - Pfizer Acquires Rights to Alzheimer's Drug
The New York Times - A Regeneron Drug Minimized Recurrence of Gout in Clinical Trial
The New York Times - Marriage problems? Husband's genes may be to blame
Reuters - High blood calcium tied to lethal prostate cancer
Reuters - Big pharma gravitates to the academe
Financial Times - Cancer, diabetes leave fingerprints in blood, serum
Reuters - Google's Philanthropy Arm Leads Effort to Use Weather Data to Fight Disease
The New York Times - Doubts Grow Over Flu Vaccine in Elderly
The New York Times - Shionogi to Buy Sciele Pharma to Get U.S. Sales Staff
Bloomberg - Cracking enzyme code opens way to new cancer drugs
AFP - Obesity not a red flag for spotting diabetes
Reuters - Bringing Good Things To Life (Science)?
The Scientists - GSK signs $820M drug development deal
Triangle Business Journal - Sleep quality drops with age, but effects diminish
Reuters - Antipsychotic drugs double stroke risk: study
Reuters - Independent WHO study backs universal health care
Reuters - H.I.V. Is Spreading in New York City at Three Times the National Rate, a Study Finds
The New York Times - Deafness breakthrough as doctor grows critical cell type
The Times - Amgen to Stop Offering Discounts on Anemia Drug
Reuters - Fertility treatments induce gene mutations: study
Reuters - Scientists Reprogram Adult Cells' Function
The Washington Post - Survey finds causes of cancer little understood
Reuters - Novartis' Glivec gets FDA priority review
Reuters - Biologist Doug Melton talks about how disease-specific stem cells will reshape medicine
Technology Review - Novavax Moves Closer to Licensing Bird Flu Vaccine
The Washington Post - Census: Number of uninsured dropped in 2007
MSNBC - California stop-smoking campaign saved $86 billion: report
Reuters - Stanford to Limit Drug Maker Financing
The New York Times - Cancer Test for Women Raises Hope, and Concern
The New York Times - Two experiments suggest new direction for diabetes
Reuters - Uninsured pay $30 billion for health care
Reuters - Gilead's hiring plan: 1,900 new jobs
The San Francisco Business Times - Gastric bypass surgery reverses metabolic syndrome
Reuters - Human exoskeleton suit helps paralyzed people walk
Reuters - FDA approves Amgen drug Nplate to treat blood clotting disorder
The Los Angeles Times - Measles Cases Grow in Number, and Officials Blame Parents' Fear of Autism
The New York Times - Drugmakers Given Legal Shield By Rule, Lawyers Say
Bloomberg - Genentech to Pay Retention Bonuses
The New York Times - Judge Orders Drug Maker to Provide Experimental Treatment to Terminally Ill Teenager
The New York Times - DHEA may not boost brain power, well-being
Reuters - Report Rejects Medicare Boast of Paring Fraud
The New York Times - Biotech buyout action likely to continue
CNNMoney - Stem-cell, state reform get enough signatures
Detroit Free Press - Vaccine refusals fuel measles outbreak
Reuters - "Good" fat may be new weapon in obesity fight
Reuters - Researchers Question Wide Use of HPV Vaccines
The New York Times - Judge Orders Drug Maker to Provide Experimental Treatment to Terminally Ill Teenager
The New York Times - Matsushita says new DNA technology identifies disease risks
AFP - NIST study helps stabilize protein drugs
UPI - California Licenses 2 Companies to Offer Gene Services
The New York Times - Drug Makers' Push Leads to Cancer Vaccines' Fast Rise
The New York Times - Medicine tailored to your genome, not your race: Venter
AFP - Consumers face rising medical debt: survey
Reuters - Researchers produce blood in lab from stem cells
The Los Angeles Times
Back « 1 2
3 4 5 6 7 ... » Next
